Literature DB >> 23597496

Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies.

C Varnoux1, C Huchon, A S Bats, C Bensaid, A Achouri, C Nos, F Lécuru.   

Abstract

OBJECTIVES: Residual disease after excision surgery is the main prognostic factor in advanced ovarian cancer. Open surgery can delay neoadjuvant chemotherapy initiation. Therefore, a minimally invasive method for evaluating resectability would be of great interest. Aim of our study is to evaluate a new technique for assessing the extent of peritoneal carcinomatosis, combining manual palpation and standard laparoscopy.
METHODS: Prospective single-center study from October 2008 to January 2010. Patients with peritoneal carcinomatosis from gynecological malignancies were investigated by standard laparoscopy followed by laparoscopy plus manual palpation using Lapdisc(®) (Ethicon Inc.), at 43 abdominopelvic sites. When both techniques indicated resectability, standard cytoreduction surgery was performed via a midline laparotomy. The Fagotti, modified Fagotti, and Sugarbaker scores were computed. The diagnostic performance of each evaluation criterion was assessed by computing sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver-operating characteristic curves (ROC-AUCs).
RESULTS: Of the 29 included patients, 18 (62.1%) were considered to have resectable disease. Fourteen (14/18, 77.8%) had macroscopically complete cytoreduction. With Lapdisc(®), sensitivity was 100%, specificity 73.3%, PPV 77.8%, NPV 100%, and ROC-AUC 0.87. Corresponding values were as follows: laparoscopy, 100%, 40%, 60.9%, 100%, and 0.70; Fagotti and modified Fagotti scores, 100%, 46.7%, 63.6%, 100%, and 0.73; Sugarbaker score, 64.3%, 93.3%, 90%, 73.7%, and 0.79. The ROC-AUCs showed significantly better performance of Lapdisc(®) than of standard laparoscopy (P = 0.008).
CONCLUSION: Hand-assisted laparoscopy may perform better than laparoscopy alone for predicting the resectability of peritoneal carcinomatosis by increasing the number of sites evaluated.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23597496     DOI: 10.1016/j.ejso.2013.03.022

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Clinical perspectives for the use of total body PET/CT.

Authors:  Ronan Abgral; David Bourhis; Pierre-Yves Salaun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06       Impact factor: 9.236

2.  The Utility of Hand-Assisted Laparoscopic Surgery (HALS) in Giant Pelvic Masses.

Authors:  Xuyin Zhang; Jingxin Ding; Keqin Hua
Journal:  Indian J Surg       Date:  2015-03-11       Impact factor: 0.656

3.  Feasibility of hand-assisted laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy.

Authors:  George I Salti; Samer A Naffouje
Journal:  Surg Endosc       Date:  2018-06-20       Impact factor: 4.584

Review 4.  Surgical technology and pharmacology of hyperthermic perioperative chemotherapy.

Authors:  Paul H Sugarbaker; Kurt Van der Speeten
Journal:  J Gastrointest Oncol       Date:  2016-02

5.  Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: prospective validation. "The times they are a-changin"?

Authors:  Marcello Ceccaroni; Giovanni Roviglione; Francesco Bruni; Roberto Clarizia; Giacomo Ruffo; Matteo Salgarello; Michele Peiretti; Stefano Uccella
Journal:  Surg Endosc       Date:  2017-10-19       Impact factor: 4.584

6.  A Versatile Theranostic Platform for Colorectal Cancer Peritoneal Metastases: Real-Time Tumor-Tracking and Photothermal-Enhanced Chemotherapy.

Authors:  Tao Sun; Guangping Zhang; Tingting Ning; Qinjun Chen; Yongchao Chu; Yifan Luo; Haoyu You; Boyu Su; Chao Li; Qin Guo; Chen Jiang
Journal:  Adv Sci (Weinh)       Date:  2021-08-16       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.